Jeffrey J. Brown - 25 Jun 2025 Form 4 Insider Report for MEDIFAST INC (MED)

Reporting relationship: Director
Issuer ticker: MED
Reported as of: 25 Jun 2025
Net transaction value: +$126,528
SEC form: 4
Accepted by SEC: 26 Jun 2025, 19:02:59 UTC
Prior SEC filing: 07 May 2025
Next SEC filing: 01 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Jason L. Groves, attorney-in-fact

Key filing fact

Jeffrey J. Brown filed Form 4 for MEDIFAST INC (MED) on 26 Jun 2025.

Key facts

This page summarizes Jeffrey J. Brown's Form 4 filing for MEDIFAST INC (MED).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 26 Jun 2025, 19:02.

Change

Previous filing in this sequence was filed on 07 May 2025.
Current net transaction value: +$126,528.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001245377 Primary reporting owner

BROWN JEFFREY J

Relationship: Director
Address: C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE
Signature: /s/ Jason L. Groves, attorney-in-fact
Signature date: 26 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MED transaction

Common Stock

Award

Transaction value: $0
Shares: +11,168
Change %: +62%
Price: $0.000000
Shares after: 29,128
Date: 25 Jun 2025
Ownership: Direct
Footnotes: F1

MED transaction

Common Stock

Award

Transaction value: $126,528
Shares: +9,449
Change %: +32%
Price: $13.39
Shares after: 38,578
Date: 25 Jun 2025
Ownership: Direct
Footnotes: F2, F3

MED holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,233
Date: 25 Jun 2025
Ownership: Jeffrey Brown Living Trust
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026.

Footnote F2

The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.

Footnote F3

The price per share of $13.39 is based on the 20-day moving average stock price of the Issuer's common stock as of June 6, 2025.

Footnote F4

These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.